Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children
Hemophagocytic lymphohistiocytosis (HLH) during childhood cancer treatment is a rare adverse event posing major diagnostic and therapeutic challenges. Between 1995 and 2006, 6 children developed HLH while on conventional chemotherapy (n=4) or after allogeneic stem cell transplantation (n=2). Treatme...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2008-02-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/4753 |